Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Qualitative Exploration of the Impact of Positive BRCA 1/2 Mutation Status on the Lives of Young Women

NCT00858078 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00858078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Qualitative Exploration of the Impact of Positive BRCA 1/2 Mutation Status on the Lives of Young Women
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
June 21, 2011
Completion date
April 3, 2015
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 gene, brca2 gene